Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Needham

C3.ai Stock Falls As Analysts Flag Sharp Sales Decline And Wider Losses

The artificial intelligence sector has been experiencing rapid growth and transformation, attracting significant investor interest in recent years. However, navigating the volatility and challenges faced by AI firms remains a crucial concern for stakeholders.

Benzinga

Zscaler Beats Q4 Estimates, Analysts Mixed On Price Targets Despite Growth

Zscaler Inc (NASDAQ:ZS) shares were down on Wednesday morning, even after the company reported upbeat fiscal fourth-quarter results.

Benzinga

Alphabet To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Dollar Tree To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Nutanix Poised To Capture Market Share With Expanding Cloud Platform And VMware Disruption: Analyst

Nutanix (NASDAQ:NTNX) ended fiscal 2025 with a stronger-than-expected fourth quarter, posting double-digit revenue growth and signaling traction from large strategic deals and deepening industry partnerships. Yet, near-term contract timing issues clouded investor sentiment, sending shares lower.

Benzinga

BILL Holdings Gains Analyst Support For Fintech Expansion, Cross-Sell Momentum, AI-Driven Growth Plans

BILL Holdings (NYSE:BILL) reported on Wednesday a strong fiscal fourth quarter with revenue and EPS beats, driven by customer growth, cross-sell momentum and product innovation.

Benzinga

Pure Storage Reports Q2: Stock Soars, Analysts Revise Forecasts

Pure Storage Inc (NYSE:PSTG) shares rallied in early trading on Thursday, after the company reported upbeat fiscal second-quarter results.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

CrowdStrike Analysts Emphasize Long-Term Strength Of Cybersecurity Platform

As the tech sector navigates a landscape of economic uncertainty and rapid innovation, cybersecurity firms are increasingly in the spotlight for their critical role in safeguarding digital assets. Amid this broader industry trend, CrowdStrike Holdings Inc. (NASDAQ:CRWD) has captured investor attention with its robust financial performance and strategic growth initiatives.

Benzinga

Snowflake Analysts Raise Forecasts As Stock Jumps To 52-Week High On Strong Results

As the demand for data-driven insights and cloud-based solutions intensifies, companies providing these services are experiencing significant growth and investor interest. Snowflake Inc. (NYSE:SNOW), a leader in data cloud services, is at the forefront of this trend, capturing attention with its robust financial performance and strategic innovation.

Benzinga

Nvidia Q2 Guidance Shows Demand Outstrips Supply For 'New Oil And Gold Of AI Revolution'

Nvidia Corporation (NASDAQ:NVDA) analysts are highlighting the company's growth in the second quarter and pending opportunity as China regulations become clear.

Benzinga

MongoDB Scores Best Day Ever After Earnings Beat—Here's What Wall Street Thinks

MongoDB Inc. (NASDAQ:MDB) is enjoying its biggest one-day rally since going public in 2017.

Benzinga

Medtronic To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Rivian's Affordable R2 May Unlock Massive Market Potential, Analyst Says

Rivian Automotive’s (NASDAQ:RIVN) upcoming R2 SUV could drive significant growth, with Needham analyst Chris Pierce projecting strong demand and a larger market reach.

Benzinga

Dayforce, Thoma Bravo Deal Has Some Analysts Wanting More

Dayforce Inc (NYSE:DAY) agreed to a take-private deal with Thoma Bravo on Thursday, and two analysts promptly downgraded the stock.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Zoom Boasts 11-Quarter Growth Streak, Raises 2026 Guidance

Shares of Zoom Communications Inc (NASDAQ:ZM) rallied Friday after the company reported upbeat fiscal second-quarter earnings.

Benzinga

Hewlett Packard Enterprise To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Barchart

Can Rocket Lab Stock Hit $55 in 2025?

RKLB stock has impressed with consistent growth and analyst optimism. Could this momentum propel shares to $55?

Benzinga

On Holding Posts Strong Beat-And-Raise Q2 As 'Select Price Increases' Offset Tariff Costs

Shares of On Holding AG (NYSE:ONON) declined in early trading on Wednesday, despite the company reporting upbeat second-quarter results.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

CoreWeave's AI Demand Surges But Expansion Spending Cuts Into Profitability

CoreWeave (NASDAQ:CRWV) shares tumbled on Wednesday after the AI-focused cloud computing provider posted mixed second-quarter results, highlighting surging revenue and backlog alongside margin pressures from an aggressive expansion plan.

Benzinga

Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum

On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated New Drug Application (ANDA) for Iron Sucrose Injection, USP 50mg/2.5mL, 100mg/5mL, and 200mg/10mL in single-dose vials, previously referred to as AMP-002.

Benzinga

What's Going On With Etsy Stock?

Shares of Etsy Inc (NASDAQ:ETSY) are trading higher Tuesday, adding to gains of approximately 18% over the past week. Here’s what investors need to know.

Benzinga

Archer Aviation Q2 Disappoints: First Revenue Stream In Sight?

Shares of Archer Aviation Inc (NYSE:ACHR) recorded gains in trading on Tuesday, despite a downbeat second-quarter report.

Benzinga

Analysts Turn Cautious On Crocs After Underwhelming Guidance

Crocs, Inc. (NASDAQ:CROX) reported Thursday that its second quarter adjusted earnings per share were $4.23, beating the consensus estimate of $4.01. Additionally, it reported sales of $1.14 billion, which aligns with the consensus estimate.

Benzinga

Datadog Faces Analyst Warning As OpenAI Spending Risks Threaten Future Growth

Wall Street analysts rerated Datadog (NASDAQ:DDOG) after the company reported its quarterly results on Thursday. The stock traded lower on Friday.

Benzinga

Twilio Exceeds Q2 Expectations, Stock Price Dips Despite AI Ramp

Shares of Twilio Inc (NYSE:TWLO) were down nearly 20% at last check Friday, despite the company’s upbeat second-quarter report.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.